Tanezumab

First-in-Class Chronic Pain Drug Candidate Fast Tracked

First-in-Class Chronic Pain Drug Candidate Fast Tracked

By

Tanezumab is a NGF inhibitor and is a first-in-class agent to receive Fast Track approval.

Sign Up for Free e-Newsletters